High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)
Clinical trial NCT04126460 · UNKNOWN
Trial details
- NCT number
- NCT04126460
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-10
- Primary completion
- 2021-09-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.